Accessibility Menu
 
Grifols logo

Grifols

(NASDAQ) GRFS

Current Price$7.56
Market Cap$1.96B
Since IPO (2011)+32%
5 Year-51%
1 Year-2%
1 Month-22%

Grifols Financials at a Glance

Market Cap

$1.96B

Revenue (TTM)

$7.51B

Net Income (TTM)

$401.08M

EPS (TTM)

$0.67

P/E Ratio

11.25

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$7.56

Volume

1,560,287.264

Open

$7.77

Previous Close

$7.58

Daily Range

$7.51 - $7.77

52-Week Range

$6.19 - $11.14

GRFS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grifols

Industry

Biotechnology

Employees

25,258

CEO

Nacho Abia Buenache, MBA

Headquarters

Barcelona, 08174, ES

GRFS Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

17%

Net Income Margin

5%

Return on Equity

7%

Return on Capital

7%

Return on Assets

2%

Earnings Yield

8.89%

Dividend Yield

0.00%

Payout Ratio

31.85%

Stock Overview

Market Cap

$1.96B

Shares Outstanding

258.22M

Volume

1.56M

Short Interest

0.00%

Avg. Volume

606.68K

Financials (TTM)

Gross Profit

$2.58B

Operating Income

$1.19B

EBITDA

$1.62B

Operating Cash Flow

$1.01B

Capital Expenditure

$254.54M

Free Cash Flow

$751.14M

Cash & ST Invst.

$824.65M

Total Debt

$8.74B

Grifols Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.96B

-0.6%

Gross Profit

$680.40M

-11.2%

Gross Margin

34.66%

N/A

Market Cap

$1.96B

N/A

Market Cap/Employee

$82.13K

N/A

Employees

23,833

N/A

Net Income

$97.33M

+41.1%

EBITDA

$395.71M

+17.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.92B

+12.9%

Accounts Receivable

$844.64M

-21.7%

Inventory

$3.29B

-7.5%

Long Term Debt

$8.35B

-11.6%

Short Term Debt

$385.84M

-39.7%

Return on Assets

2.04%

N/A

Return on Invested Capital

7.21%

N/A

Free Cash Flow

$335.21M

-19.1%

Operating Cash Flow

$418.64M

-18.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CORTCorcept Therapeutics Incorporated
$34.64+1.64%
AVTRAvantor, Inc.
$7.51-1.31%
BIOBio-Rad Laboratories, Inc.
$264.49-0.19%
MOHMolina Healthcare, Inc.
$139.41-1.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About GRFS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.